know more, do more

Advancing endocrinology and improving public health

Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field. 

the latest
Meetings & Events

Register Today for ENDO 2025 in San Francisco, CA

May 27, 2025

Join us in San Francisco, CA, USA, July 12-15, 2025, for ENDO 2025. With over 7,000 attendees, nearly 2,500 abstracts and over 200 other sessions, ENDO is the leading global meeting on endocrinology research and clinical care. ENDO’s comprehensive program provides attendees the opportunity to learn about the latest developments in hormone science and medicine from renowned investigators, expert clinicians, and educators from all over the world.

Meetings & Events

Using Teriparatide: Combination and Sequential Therapies Member Webinar

June 03, 2025

On Tuesday, June 17 at 1:00 PM ET, we’ll explore how to effectively integrate teriparatide into treatment plans. Participants will learn best practices for both sequential and concomitant use of teriparatide with other agents, helping to inform safe and effective decision-making in clinical practice. Register now.

Store

Elevate Pediatric Care With Pediatric ESAP™ 2025–2026

June 04, 2025

Navigate the complexities of endocrine care for children and adolescents with the Pediatric Endocrine Self-Assessment Program (ESAP)™ 2025–2026. Enhance patient care with 100 new case-based questions covering growth, diabetes, reproduction, and more. Available in print, eBook, and online, with interactive modes to build knowledge and confidence. Order now.

Training & Education

Introducing the 2025 MSEP Awardees

May 30, 2025

We are excited to announce the medical schools chosen for the second year of our Medical School Engagement Program (MSEP). Our chosen recipients stood out with exceptional leadership in education, innovative approaches, and unwavering commitment to advancing the field of endocrinology by increasing medical students’ exposure to all the exciting aspects of this specialty.

Advocacy

Advocacy in Action

June 06, 2025

Understand the latest happenings in the policy world, including the Senate introduction of the Treat and Reduce Obesity Act and new information about the President's budget request for Fiscal Year 2026.

We Are Endocrinology

Deena Adimoolam
“I use media to share a message of prevention and recognition of many endocrine diseases, especially diabetes and obesity. As a member of the Endocrine Society, I have also had the opportunity to continue this work with Society members who share in my vision and passion. I work closely with the Endocrine Society’s Hormone Health Network to spread awareness on various endocrine diseases through patient education tools and media.” – Deena Adimoolam, MD
We are an 18,000 member strong global community
A champion for the Society’s guidelines, Chris has been passionate about improving our guideline development methodology as well as about making guideline content more accessible to readers around the world. – Christopher McCartney, MD

Advantages of Membership

Need more info?

Learn more about the advantages of membership

Endocrine Society News

AMA passes resolution calling for expanded access to anti-obesity medications

June 10, 2025

The American Medical Association (AMA) House of Delegates today passed the Endocrine Society’s resolution to improve access to anti-obesity medications.

Endocrine Society endorses Treat and Reduce Obesity Act

June 05, 2025

The Endocrine Society today endorsed the introduction of the bipartisan Treat and Reduce Obesity Act (TROA) in the Senate.

Sriram Gubbi of NIDDK wins Endocrine Society’s 2025 Endocrine Images Art Competition

May 22, 2025

Sriram Gubbi, MD, won the Endocrine Society’s 2025 Endocrine Images Art Competition with his microphotograph of follicular thyroid carcinoma cells titled “The Cosmic Bubble”.

View More

Featured Journal Articles

Transient Blindness in Metformin-Associated Lactic Acidosis

June 10, 2025

The authors present a 62-year-old woman with type 2 diabetes (T2DM) and stage 3A chronic kidney disease (CKD) who presented to the emergency department with a 3-day history of nausea, vomiting, diarrhea, and abdominal pain.

Association of OGTT-Curve Shape With Anthropometric, Metabolic, and Inflammatory Parameters in Healthy Adults

June 10, 2025

In this study, we analyzed which parameters are associated with different oral glucose tolerance test-curve shapes in healthy middle-aged and older adults.

Sex-Specific Association of Chronic Proton Pump Inhibitor Use With Reduced Bone Density and Quality

June 10, 2025

The primary aim of this study was to evaluate whether trabecular bone microarchitecture, assessed by trabecular bone score, is altered in chronic proton pump inhibitor users.

View More
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.